Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients

Caterina Sagnelli(University of Campania "Luigi Vanvitelli"), Evangelista Sagnelli(University of Campania "Luigi Vanvitelli"), Laura Galli(Vita-Salute San Raffaele University), Luca Albarello(University of Insubria), Giuseppe Di Pasquale(Population Health Research Institute), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Carlo Doglioni(San Raffaele University of Rome), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Adriano Lazzarin(Vita-Salute San Raffaele University)
The Brazilian Journal of Infectious Diseases
October 25, 2013
10.1016/j.bjid.2013.06.005
Cited by 11

Related Papers

Complete Revascularization with Multivessel PCI for Myocardial Infarction
|New England Journal of Medicine|2019|926
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173